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Abstract
Atherosclerosis is the main cause of coronary heart disease and stroke, the two major causes of death in developed society.
There is emerging evidence of excess risk of cardiovascular disease at low radiation doses in various occupationally exposed
groups receiving small daily radiation doses. Assuming that they are causal, the mechanisms for effects of chronic
fractionated radiation exposures on cardiovascular disease are unclear. We outline a spatial reaction-diffusion model for
atherosclerosis and perform stability analysis, based wherever possible on human data. We show that a predicted
consequence of multiple small radiation doses is to cause mean chemo-attractant (MCP-1) concentration to increase linearly
with cumulative dose. The main driver for the increase in MCP-1 is monocyte death, and consequent reduction in MCP-1
degradation. The radiation-induced risks predicted by the model are quantitatively consistent with those observed in a
number of occupationally-exposed groups. The changes in equilibrium MCP-1 concentrations with low density lipoprotein
cholesterol concentration are also consistent with experimental and epidemiologic data. This proposed mechanism would
be experimentally testable. If true, it also has substantive implications for radiological protection, which at present does not
take cardiovascular disease into account. The Japanese A-bomb survivor data implies that cardiovascular disease and cancer
mortality contribute similarly to radiogenic risk. The major uncertainty in assessing the low-dose risk of cardiovascular
disease is the shape of the dose response relationship, which is unclear in the Japanese data. The analysis of the present
paper suggests that linear extrapolation would be appropriate for this endpoint.
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Introduction
Atherosclerosis is the main cause of coronary heart disease and
stroke, the two major causes of death in developed society [1].
Though previously initiation of atherosclerosis was attributed
mainly to lipid accumulation within the arterial walls, it is now
widely accepted that inflammation plays a vital role in the
initiation and progression of the disease [2–5].
For some time cardiovascular effects of high dose radiotherapy
(RT) have been known [6,7]. A variety of effects are observed,
presumed to result from inactivation of large numbers of cells and
associated functional impairment of the affected tissue. Among
such effects are direct damage to the structures of the heart –
including marked diffuse fibrotic damage, especially of the
pericardium and myocardium, pericardial adhesions, microvascu-
lar damage and stenosis of the valves 2 and to the coronary
arteries; these sorts of damage occur both in patients receiving RT
and in experimental animals [6]. There is emerging evidence of
excess risk of cardiovascular disease at much lower radiation doses
and occurring a long time after radiation exposure in the Japanese
atomic bomb survivor Life Span Study (LSS) cohort [8,9] and in
various occupationally-exposed groups [10–14] although not in all
(e.g., [15]). Assuming that they are causal, the likely mechanisms
for such effects of low dose and/or chronic radiation exposures on
cardiovascular disease are not clear [16,17]. It is of interest that
elevated levels of the pro-inflammatory cytokines IL-6, CRP,
TNF-a and INF-c, but also increased levels of the (generally) anti-
inflammatory cytokine IL-10, have been observed in the Japanese
atomic bomb survivors [18,19]. There was also dose-related
elevation in erythrocyte sedimentation rate and in levels of IgG,
IgA and total immunoglobulins in this cohort, all markers of
systemic inflammation [19].
In this paper we outline a mathematical formulation of a model
of cardiovascular disease that is largely based on the inflammatory
hypothesis articulated by Ross [2,3]. The motivation behind the
mathematical modelling is to encompass various factors contrib-
uting to the inflammatory process and subsequently to athero-
sclerotic formation. As atherosclerosis is not only a multifactorial,
but also a multi-step disease, we concentrate on modelling chronic
inflammation, primarily at early stages in the disease, but
outlining a treatment for the later stages that lead to plaque
rupture. The model is to some extent based on a model of McKay
et al. [20], although there are significant departures from and
elaborations of this model. In particular, features are borrowed
from the generally rather simpler models of Cobbold et al. [21]
and Ibragimov et al. [22]. Stability analysis of a simplified version
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concerned with mechanisms for effects of cholesterol and
fractionated low dose radiation exposure in this inflammation
model, and outline a case for radiation-induced monocyte cell
death as a candidate pathway.
Models
Spatial atherosclerosis model
In this section we shall consider a spatial atherosclerosis model
based on a simplification of the biology outlined in Text S1 section
A.1. The model is entirely concerned with processes in the intima
(the tissue immediately adjacent to the endothelial cell lining of the
arteries), VI, where the disease process is thought to be initiated,
with boundary conditions determined in part by species
concentrations in the lumen, VL. Specifically, the model is
concerned with atherosclerosis in the large arteries, for example
the coronary, carotid and other cerebral arteries, lesions in which
account for the largest part of cardiovascular morbidity and
mortality [4]. In Text S1 section A.2 we outline a rather fuller
version of this spatial model, incorporating more of the biological
detail of section A.1 of Text S1. The main point of the section is
the stability analysis that we perform in the final part, this being
the reason for the simplifications. The processes are a combination
of stage 2 and stage 3 processes outlined in section A.1 of Text S1.
The set of reaction-diffusion equations is as follows:
dE0
dt
~t(E0ss{E0){
X Nmax,L{1
i~0
iLiE0Li ð1Þ
dE1
dt
~
X Nmax,L{1
i~0
iLiE0Li{dEE1 ð2Þ
LC
Lt
~
rCEE1zrCMMzrCTTzDC+2C{dCMMC{dCTTC{dCmmC
ð3Þ
LP
Lt
~rPTTzDP+2P ð4Þ
Lm
Lt
z+:½mxm(C)+C ~m½m{rM PzDm+2m ð5Þ
LM
Lt
z+:½MxM(C)+C ~rMmP{dM(g=M)MzDM+2M ð6Þ
Lg
Lt
z+:½gxM(C)+C 
~rin(g=M)ML0{dM(g=M)gz+:½(g=M)DM+M 
ð7Þ
LT
Lt
z+:½TxT(C)+C ~{dTTzDT+2T ð8Þ
LN
Lt
~dM(g=M)½gzdMMM zdTdTTT ð9Þ
where E0,E1 are the undamaged and damaged EC concentra-
tions, C is the chemo-attractant (monocyte chemo-attractant
protein 1 (MCP-1)) concentration, P is the proliferation factor
(macrophage colony-stimulating factor (M-CSF)), m is the
monocyte concentration, M is the macrophage concentration, g
is the bound lipid concentration and N is the necrotic core
concentration. Li is the LDL concentration with oxidation state i
(the number of vitamin E molecules unoxidized - 1) (so L1 is the
LDL with all vitamin E oxidized, although itself unoxidised and L0
is the fully oxidised LDL concentration). xm(C),xM(C),xT(C) are
the chemotactic factors (assumed constant) associated with
monocytes, macrophages and T-lymphocytes, respectively; the
mechanism for chemotaxis (as given by the terms involving these
coefficients) is similar to that of Keller and Segel [23,24].
DC,DP,Dm,DM,DT are the rates of diffusion of the associated
species. MCP-1 (also known as CCL2) is known to recruit
monocytes, T-lymphocytes and dendritic cells to sites of tissue
injury. Table S1 gives further details of candidate molecules for
some of the model variables.
While many of the components of these equations are standard
(further details are given in Text S1 section A), a few deserve further
explanation. In equation (3) we assume that chemo-attractant is
degraded (via the term {dCMMC{dCTTC{dCmmC)a tar a t e
proportional to the concentration of macrophages, T-cells and
monocytes; McKay et al. [20] do not assume such degradation. We
assume this because chemo-attractant molecules are assumed to
adheretocell-surfacemarkersonthesecellspecies(themechanismby
which theyare assumed to attract);a similarassumption was made by
Ibragimov et al. [22]. In equation (7) we assume that the bound lipid
concentration, g, is increased (internalised within macrophages) at a
rate determined by the concentration of macrophages, M,a n dt h e
concentration of fully oxidized LDL, L0 (the rinML0 term in
equation (7)), but that this bound lipid is released when the
macrophages die (the {dM(g=M)M(g=M)~{dM(g=M)g term
in equation (7)), a function of macrophage concentration and bound
lipid concentration, as given in McKay et al. [20]. As discussed
in Text S1 section A (equations (A.23)–(A.24) and preceding), we shall
assume that rin g=M ðÞ ~rin,highz½rin,0{rin,high exp½{R3g=M 
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equation (6), is given by JM~xM(C)M+C{DM+M. Therefore
the bound lipid flux (all carried by macrophage diffusion and chemo-
taxis)is Jg~
g
M
½xM(C)M+C{DM+M ~gxM(C)+C{
g
M
DM+M.
This leads to a chemotaxis term gxM(C)+C similar to that assumed
by McKay etal.[20]. We obtain a diffusion term that isentirelydue to
macrophage diffusion, +:½(g=M)DM+M ~DM (1=M)+g:+M{ ð
(g=M2)+M:+Mz(g=M)+2MÞ, in contrast with McKay et al. who
assume a standard diffusion term in the lipid, Dg+2g;w ef a i lt os e e
how bound lipid can diffuse apart from macrophages - by definition it
is bound within macrophages. [+:~
L
Lx
z
L
Ly
z
L
Lz
is the divergence
(div) operator, +~
L
Lx
,
L
Ly
,
L
Lz
  
is the gradient (grad) operator and
+2~
L
2
Lx2 z
L
2
Ly2 z
L
2
Lz2 is the Laplacean operator.] Further details
are given in Text S1 section A.
Boundary conditions
Let P be the outward unit normal on the boundary
(LVI|LVL), where LVL is the boundary between intima and
lumen, and LVI is the boundary between intima and media. Then
we have:
LC
LP
~0o nLVI|LVL ð10Þ
LP
LP
~0o nLVI|LVL ð11Þ
Lm
LP
~
{bm(C,mL)~{(1=Dm)Jm(C,mL)o nLVL
0 otherwise
 
ð12Þ
LM
LP
~0o nLVI|LVL ð13Þ
Lg
LP
~0o nLVI|LVL ð14Þ
LT
LP
~
{bT(C,TL)~{(1=DT)JT(C,TL)o nLVL
0 otherwise
 
ð15Þ
LN
LP
~0o nLVI|LVL ð16Þ
[mL,TL are the monocyte and T-lymphocyte concentrations on
the immediate lumenal side of the EC layer.] These boundary
conditions are similar to those assumed by Ibragimov et al. [22].
Note that in (12) and (15) we convert from the monocyte and
T-lymphocyte flux (Jm(C,mL),JT(C,TL) respectively) to the rate
of change of concentration per unit distance (bm(C,mL),bT(C,TL)
respectively) via the inverse of the respective diffusion constants.
We assume the following parametric form of the boundary
monocyte and T-lymphocyte flux in (12) and (15):
Jm(C,mL)~
Dmbm(C,mL)~DmmL:max½bm,0zbm,1C,0 1CwCTm on C1
0 otherwise
 
ð17Þ
JT(C,TL)~
DTbT(C,TL)~DTTL:max½bT,0zbT,1C,0 1CwCTT on C1
0 otherwise
 
ð18Þ
The fundamentally linear form of these is inspired by data in
Takaku et al. [25] and Klouche et al. [26]. The threshold levels of
chemo-attractant, CTm,CTT, below which these fluxes are zero, is
inspired by similar assumptions made by Ibragimov et al. [22]; as
we discuss below, non-zero threshold levels are needed for there to
be a stable solution.
Results
Equilibrium solution
We assume that the system is in spatial and temporal
equilibrium at some time t0, and is subject to some perturbation
after that point. Let E0,eq,E1,eq,:::,Neq be the equilibrium values of
the various quantities, and let E0,D,E1,D,:::,ND be the differences
from these equilibrium values after perturbation – so that, for
example, E0~E0,eqzE0,D, and similarly for the other species.
Therefore, for E0,eq,E1,eq,:::,Neq to be the equilibrium values we
have by (1)–(9):
E0,eq~
tE0ss
tz
P Nmax,L{1
i~0
iLiLi
ð19Þ
E1,eq~
E0,eq
dE
X Nmax,L{1
i~0
iLiLi ð20Þ
rCEE1,eqzrCMMeqzrCTTeq
~dCMMeqCeqzdCTTeqCeqzdCmmeqCeq
ð21Þ
rPTTeq~0 ð22Þ
mmeqPeq~rMmeqPeq ð23Þ
rMmeqPeq~dM(geq=Meq)Meq ð24Þ
rin(geq=Meq)MeqL0~dM(geq=Meq)geq ð25Þ
dTTeq~0 ð26Þ
dM(geq=Meq)½geqzdMMMeq zdTdTTTeq~0 ð27Þ
In order that the system be in equilibrium, the boundary monocyte
and T-lymphocyte flux must be zero, so we must have that
Ceqvmin½CTm,CTT ; for the remainder of this section we
Model for Cardiovascular Disease
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(rPT=0, dM(geq=Meq)=0, dMM=0, m=rM) these simplify to (19)
and (20) and:
Teq~geq~Meq~meqPeq~0 ð28Þ
rCEE1,eq~dCmmeqCeq ð29Þ
Putting together (19), (20) and (29) we see that:
Ceq~
rCEtE0,ss
P Nmax,L{1
i~0
iLiLi
 !
dCmmeqdE tz
P Nmax,L{1
i~0
iLiLi
 ! ð30Þ
This implies a non-linear relationship between LDL (Li)
Nmax,L{1
i~0
and the equilibrium chemo-attractant level Ceq. However, as is
clear from Figures 1–2, only for very high levels of LDL, multiples
in excess of 50 of the baseline levels (see Table S3), are there
appreciable departures from linearity.
WeshalloftenassumethatPeq~0.Inallthatfollowsweassumea
limiting process, so that limgeq,Meq?0dM(geq=Meq)~dM(0)~dM,0,
limgeq,Meq?0rin(geq=Meq)~rin(0)~rin,0. If we perform the obvious
linearisations in equations (1)–(9) and ignore all second and higher
order terms in E0,D,E1,D,:::,ND we obtain:
dE0,D
dt
~{tE0,D{
X Nmax,L{1
i~0
iLiE0,DLi ð31Þ
dE1,D
dt
~
X Nmax,L{1
i~0
iLiE0,DLi{dEE1,D ð32Þ
LCD
Lt
~rCEE1,DzrCMMDzrCTTDzDC+2CD{dCMMDCeq
{dCTTDCeq{dCm½mDCeqzmeqCD 
ð33Þ
LPD
Lt
~rPTTDzDP+2PD ð34Þ
LmD
Lt
zmeqxm(C)+2CD
~meq½m{rM PDzPeq½m{rM mDzDm+2mD
ð35Þ
LMD
Lt
~rMmeqPDzrMPeqmD{dM(0)MDzDM+2MD ð36Þ
LgD
Lt
~rin(0)MDL0{dM(0)gD ð37Þ
LTD
Lt
~{dTTDzDT+2TD ð38Þ
LND
Lt
~dM(0)½gDzdMMMD zdTdTTTD ð39Þ
The boundary conditions (10)–(16), together with (17), (18) translate
to:
Figure 1. MCP-1 concentration vs baseline LDL (small).
Equilibrium chemo-attractant (MCP-1) concentration, Ceq, as a function
of small multiples of baseline LDL level (Table S3), using parameters
given in Tables S2, S3.
doi:10.1371/journal.pcbi.1000539.g001
Figure 2. MCP-1 concentration vs baseline LDL (large).
Equilibrium chemo-attractant (MCP-1) concentration, Ceq, as a function
of large multiples of baseline LDL level (Table S3), using parameters
given in Tables S2, S3.
doi:10.1371/journal.pcbi.1000539.g002
Model for Cardiovascular Disease
PLoS Computational Biology | www.ploscompbiol.org 4 October 2009 | Volume 5 | Issue 10 | e1000539LCD
LP
~
LPD
LP
~
LmD
LP
~
LMD
LP
~
LgD
LP
~
LTD
LP
~
LND
LP
~0o nLVI|LVLð40Þ
Green’sfirstidentity(forgeneralscalarC2 functionsu,v and domain
V) states that:
ð
V
u+2vdx~{
ð
V
+u:+vdxz
ð
LV
u
Lv
LP
ds ð41Þ
Integrating (33)–(39) over the intima, VI, we have by (41) that:
d
dt
ð
VI
CDdx~rCE
ð
VI
E1,Ddxz½rCM{dCMCeq 
ð
VI
MDdx
z½rCT{dCTCeq 
ð
VI
TDdx{dCm½Ceq
ð
VI
mDdx
zmeq
ð
VI
CDdx 
ð42Þ
d
dt
ð
VI
PDdx~rPT
ð
VI
TDdx ð43Þ
d
dt
ð
VI
mDdx~meq½m{rM 
ð
VI
PDdxzPeq½m{rM 
ð
VI
mDdx ð44Þ
d
dt
ð
VI
MDdx~rMmeq
ð
VI
PDdxzrMPeq
ð
VI
mDdx{dM(0)
ð
VI
MDdxð45Þ
d
dt
ð
VI
gDdx~rin(0)
ð
VI
MDL0dx{dM(0)
ð
VI
gDdx ð46Þ
d
dt
ð
VI
TDdx~{dT
ð
VI
TDdx ð47Þ
d
dt
ð
VI
NDdx~dM(0)½
ð
VI
gDdxzdMM
ð
VI
MDdx zdTdTT
ð
VI
TDdxð48Þ
In Text S1 section B we outline solutions to (31)–(32), (42)–(48) in
various cases. As shown there, if tw0 and dEw0 then:
limt??E0,D(t)~0 and limt??E1,D(t)~0 ð49Þ
From Table S2 it is clear that these conditions are likely to
be always satisfied: t~4:6x10{6s{1w0 and dE~1x10{4s{1
w0.I fPeq~0 then using the results of Text S1 section B
((B.11)–(B.16)):
ð
VI
CD(t)dx~
~
ð
VI
PD(0)dxz
rPT
dT
ð
VI
TD(0)dx
0
B @
1
C A
½rCM{dCMCeq rM
dM(0)dCm
{Ceq½m{rM  t{
1
dCmmeq
  
2
6 6 6 4
3
7 7 7 5
{
Ceq
meq
ð
VI
mD(0)dx{
meq½m{rM rPT
Ð
VI
TD(0)dx
dT
2
0
B @
1
C AzO(exp½{dt )
ð50Þ
ð
VI
PD(t)dx~
ð
VI
PD(0)dxz
rPT
dT
ð
VI
TD(0)dxzO(exp½{dt ) ð51Þ
ð
VI
mD(t)dx~
ð
VI
mD(0)dx
zmeq½m{rM 
t
Ð
VI
PD(0)dxz
rPT
dT
Ð
VI
TD(0)dx
 !
{
rPT
dT
2
Ð
VI
TD(0)dx
8
> > > > <
> > > > :
9
> > > > =
> > > > ;
zO(exp½{dt )
ð52Þ
ð
VI
MD(t)dx~
rMmeq
Ð
VI
PD(0)dxz
rPT
dT
Ð
VI
TD(0)dx
 !
dM(0)
zO(exp½{dt )
ð53Þ
ð
VI
gD(t)dx~rin(0)L0
rMmeq
Ð
VI
PD(0)dxz
rPT
dT
Ð
VI
TD(0)dx
 !
dM(0)
2
zO(exp½{dt )
ð54Þ
ð
VI
ND(t)dx~
ð
VI
ND(0)dxz
ð
VI
gD(0)dx
z
dTT{
rin(0)L0rMmeqrPT
dT
2dM(0)
{
dMMrMmeqrPT
dT
2
2
6 6 6 4
3
7 7 7 5
ð
VI
TD(0)dxz
rin(0)L0
dM(0)
zdMM
  
ð
VI
MD(0)dx
ð
VI
PD(0)dxz
rPT
dT
ð
VI
TD(0)dx
0
B @
1
C A
rin(0)L0rMmeq t{
2
dM(0)
  
dM(0)
zdMMrMmeq t{ 1
dM(0)
  
2
6 6 6 6 6 4
3
7 7 7 7 7 5
zO(exp½{dt )
ð55Þ
for some dw0, so that in general CD,PD,mD,MD,gD,ND do not
decayto 0 as t??, although by (B.18) TD does(at least inL2). Note
Model for Cardiovascular Disease
PLoS Computational Biology | www.ploscompbiol.org 5 October 2009 | Volume 5 | Issue 10 | e1000539in particular that unless m~rM and rin(0)L0zdM(0)dMM~0,o r
possibly (more likely) that
Ð
VI
PD(0)dx~
Ð
VI
TD(0)dx~0, then there
will be time trends in the averaged quantities for
Ð
VI
CD(t)dx,
Ð
VI
mD(t)dxand
Ð
VI
ND(t)dx, so that in particular stability cannot be
re-attained.
In Figures 3–7 we plot the variation of the spatially-averaged
chemo-attractant, C, derived assuming a non-zero equilibrium
concentration of monocytes (Table S3) and using (B.1b’). The
perturbation is assumed to take place via killing of monocytes in
the intima, which in this case could be produced by ionizing
radiation, and also via damage to endothelial cells, produced in the
same way. We do not assume instantaneous changes in any of the
other species, i.e., TD(0)~MD(0)~PD(0)~0. The reason for this
is that by (28) Teq~Meq~Peq~0 (assuming as we do that
meqw0), so that radiation would not have any species to act on in
equilibrium. For the parameters used here (given in Tables S2 and
S3), the overwhelming contribution is via monocyte killing: by
80 seconds the contribution from this term is 4.5610
217 Mm l
21
compared with a contribution of 21.6610
218 Mm l
21 via
damage to endothelial cells. As can be seen, the change in
chemo-attractant concentration occurs (for monocytes and in
aggregate) relatively quickly, over a timescale of minutes, although
the endothelial cell killing component varies more slowly, over a
timescale of hours; after 24 hours this and all other averaged
quantities are virtually constant. In contrast to the above general
case, when only the monocyte population (of all the species) is
perturbed, for a sufficiently long time after exposure (days or more)
we have by (50), (52) that
Ð
VI
CD(t)dx&{
Ceq
meq
Ð
VI
mD(0)dx and
Ð
VI
mD(t)dx&
Ð
VI
mD(0)dx, and by (51), (53), (54) the averaged
change in all other species tends to zero. In this case we see that:
Figure 4. MCP-1 variation over 0–80 seconds after 10 mGy
(endothelial). Spatial average (over intima) of increment in chemo-
attractant (MCP-1) concentration after 10 mGy of acutely delivered
radiation, using parameters given in Tables S2, S3. The component of
changes in chemo-attractant (MCP-1) level due to endothelial cell killing
0–80 seconds after 10 mGy are shown.
doi:10.1371/journal.pcbi.1000539.g004
Figure 5. MCP-1 variation over 0–0.5 hours after 10 mGy
(monocyte, total). Spatial average (over intima) of increment in
chemo-attractant (MCP-1) concentration after 10 mGy of acutely
delivered radiation, using parameters given in Tables S2, S3. The
components of changes in chemo-attractant (MCP-1) level due to
monocyte cell killing and total (monocyte+endothelial) cell killing 0–
0.5 hours after 10 mGy are shown.
doi:10.1371/journal.pcbi.1000539.g005
Figure 3. MCP-1 variation over 0–80 seconds after 10 mGy
(monocyte, total). Spatial average (over intima) of increment in
chemo-attractant (MCP-1) concentration after 10 mGy of acutely
delivered radiation, using parameters given in Tables S2, S3. The
components of changes in chemo-attractant (MCP-1) level due to
monocyte cell killing and total (monocyte+endothelial) cell killing 0–
80 seconds after 10 mGy are shown.
doi:10.1371/journal.pcbi.1000539.g003
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Ð
VI
CD(t)dx
Ð
VI
dx
2
6 4
3
7 5 meqz
Ð
VI
mD(t)dx
Ð
VI
dx
2
6 4
3
7 5
&Ceqmeq 1{
Ð
VI
mD(t)dx
meq
Ð
VI
dx
2
6 4
3
7 5 1z
Ð
VI
mD(t)dx
meq
Ð
VI
dx
2
6 4
3
7 5&Ceqmeq
ð56Þ
approximated to first order, so that by (30), at least in average,
equilibrium can be re-established at these new values of C and m.
We conjecture that in fact equilibrium is re-established for all
quantities in this case. It is easy to see that if there were to be
further small perturbations in CD,PD,mD,MD,gD,TD,ND,a t
intervals of days or more, the resulting changes in the spatially-
averaged quantities would be approximately additive in the
corresponding increments, as shown in Figure 7. Moreover, from
(50) the excess chemo-attractant (MCP-1) in relation to the
monocyte perturbation is {
Ceq
meq
Ð
VI
mD(0)dx. Therefore, so long as
the individual monocyte perturbations are small and temporally
separated (by a day or more), the increment in chemo-attractant
will not depend on anything other than the cumulative absorbed
dose, as indicated in Figure 7.
In Figure 8 we plot the percent proportion of the population
whose cumulative chemo-attractant (MCP-1) concentration ex-
ceeds the threshold min½CTm,CTT ; as we discuss below, this
threshold is the critical point for system stability, exceedance of
which makes development of cardiovascular disease much more
likely. [The probability is derived assuming that the population
distribution MCP-1 is Gaussian with mean and standard deviation
(SD) determined by the adult female data of Cannon et al. [27]; the
mean is augmented by the radiation-induced increment, given by
(B.1b’).] For a range of threshold values between 0.25 and 1.00
Figure 8. Risk of MCP-1 exceeding threshold level vs dose.
Cumulative risk of exceeding of chemo-attractant (MCP-1) threshold
(<cumulative risk of cardiovascular disease) min[CTm,CTT], as function of
radiation dose and threshold value (mean+multiple of population SD
[27] (see Table S3)).
doi:10.1371/journal.pcbi.1000539.g008
Figure 6. MCP-1 variation over 0–0.5 hours after 10 mGy
(endothelial). Spatial average (over intima) of increment in chemo-
attractant (MCP-1) concentration after 10 mGy of acutely delivered
radiation, using parameters given in Tables S2, S3. The component of
changes in chemo-attractant (MCP-1) level due to endothelial cell killing
0–0.5 hours after 10 mGy are shown.
doi:10.1371/journal.pcbi.1000539.g006
Figure 7. MCP-1 variation over time after 10 mGy/day. As for
Figures 3–6, but assuming fractionated multiple radiation doses,
10 mGy/day.
doi:10.1371/journal.pcbi.1000539.g007
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exceeding the threshold (i.e., cardiovascular disease) of 16–40%.
Most developed countries have cumulative cardiovascular disease
mortality in the range 20–40% and the world mean is 30% [28],
so that this range of values of the MCP-1 threshold,
min½CTm,CTT , is plausible. For this range of threshold values,
Figure 8 demonstrates that risks vary remarkably linearly with
dose over the dose interval 0–4 Gy. As for Figure 7, the risk will
not depend on anything other than the cumulative absorbed dose,
as long as this is given in small daily increments.
Discussion
We have outlined a model for early stage atherosclerotic lesion
formation, and performed a stability analysis for a simplified version of
the model. While some components of the system (in particular the T-
lymphocyte concentration, T) are stable, in the sense that after
perturbations of the system the species concentrations return to their
equilibrium value, various other species, in particular the proliferation
factor concentration, P, the chemo-attractant concentration, C,t h e
monocyte concentration, m, and the necroticcore, N,aregener al lynot
stable. In particular, the mean level of chemo-attractant increases
continuously and rapidly after instantaneous perturbation by a
radiation dose, over a timescale of minutes. However, as we note
below, because of cellular repair processes, which are not taken into
account in our model, there are reasons for assuming that perturbation
by radiation would not be instantaneous, so that this process might be
extended over at least a period of hours after exposure. The main
driver for the increase in chemo-attractant is the death of monocytes
and the consequent reduction in monocyte-induced degradation in
chemo-attractant concentration, the {dCmmC term in (3). It is well
known that radiation can cause cell death [29], and the degree of cell
killing and damage that we assume is consistent with radio-biological
expectation [30,31]. Although the change in chemo-attractant (MCP-
1) concentration that we assume after 10 mGy is relatively modest,
4.5610
217 Mm l
21, a fractionated dose of 1 Gy would result in
4.5610
215 Mm l
21, comparable with the normal concentration of
MCP-1 in adult plasma, 7.9610
215 Mm l
21 [27]. The fact that the
range of excess relative risks predicted by our model, 0.49–0.93 Gy
21,
is consistent with those in a number of occupational studies (Table 1)
adds to the plausibility of this mechanism.
We have also shown that the model predicts that equilibrium
level of chemo-attractant (MCP-1) increases more or less directly
with levels of LDL, and in particular oxidized LDL, with slight
non-linearity at very high levels of MCP-1. This is in accordance
with experimental [32,33] and epidemiological observations [34].
Specifically, there is experimental evidence that addition of
minimally-oxidised LDL results in a <22-fold increase in levels
of MCP-1 in ECs in an in vitro co-culture system [32]. In a group of
baboons fed a high cholesterol, high fat diet, oxLDL in serum
increased by about 19.6% (95% 228.9, 68.1) after 7 weeks,
resulting in an increase in serum MCP-1 at that point of 66.7%
Table 1. Risks in various human cohorts, and predicted by model.
Data Reference
Endpoint (mortality unless
otherwise indicated)
Excess relative risk at 1
Gy (and 95% CI)
Japanese atomic bomb survivors Preston et al. [8] Heart disease, 1968–1997 (ICD9 390–429) 0.17 (0.08, 0.26)
ab
Stroke, 1968–1997 (ICD9 430–438) 0.12 (0.02, 0.22)
ab
Mayak workers Azizova and Muirhead [14] Ischaemic heart disease morbidity (ICD9 410–414) 0.109 (0.049, 0.168)
Cerebrovascular disease morbidity (ICD9 430–438) 0.464 (0.360, 0.567)
Chernobyl emergency workers Ivanov et al. [11] Cerebrovascular disease (ICD10 I60–I69) 0.45 (0.11, 0.80)
All circulatory disease (ICD10 I00–I99) 0.18 (20.03, 0.39)
German uranium miner study Kreuzer et al. [56] All circulatory disease (ICD10 I00–I99) 20.26 (20.6, 0.05)
Heart disease (ICD10 I00–I52) 20.35 (20.7, 0.009)
Cerebrovascular disease (ICD10 I60–I69) 0.09 (20.6, 0.8)
BNFL workers McGeoghegan et al. [12] Ischaemic heart disease (ICD9 410–414) 0.70 (0.37, 1.07)
ab
Cerebrovascular disease (ICD9 430–438) 0.66 (0.17, 1.27)
ab
All circulatory disease (ICD9 390–459) 0.54 (0.30, 0.82)
ab
UK National Registry for Radiation Workers Muirhead et al. [13] All circulatory disease (ICD9 390–459) 0.251 (20.01, 0.54)
b
US Oak Ridge workers Richardson and Wing [57] Ischaemic heart disease (ICD8 410–414) 22.86 (26.90, 1.18)
bc
IARC 15- country nuclear worker study Vrijheid et al. [15] Circulatory disease (ICD10 I00–I99, J60–J69,
O88.2, R00–R02, R57)
0.09 (20.43, 0.70)
b
Cerebrovascular disease (ICD10 O88.2) 0.88 (20.67, 3.16)
b
Predicted by model, based on chemo-attractant
(MCP-1) concentration
0.58
d
0.49–0.93
e
Excess relative risks (per Gy) of cardiovascular disease in the Japanese atomic bomb survivors and in various occupationally exposed groups, compared with excess
relative chemo-attractant (MCP-1) concentration at 1 Gy predicted by model.
a90% CI.
bExcess relative risk Sv
21.
cAssuming 10 year lag.
d1 Gy assumed given as 100 daily doses of 10 mGy, ERR evaluated by dividing excess MCP-1 concentration by baseline level from data of Cannon et al. [27].
eERR at 1 Gy of cumulative risk of exceeding threshold (<cumulative cardiovascular risk), as given by Figure 8, for levels of MCP-1 threshold min[CTm,CTT] in the range
[mean+0.25 SD, mean+1.00 SD], mean and SD taken from data of Cannon et al. [27].
doi:10.1371/journal.pcbi.1000539.t001
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relationship (without constant term) predicted by our model (30).
If radiation dose were to be given in a fractionated manner, with
doses separated by a period of hours or more, the model predicts that
chemo-attractant (e.g., MCP-1) would increase linearly with cumula-
tive accumulated dose, with a corresponding decrease in the intimal
monocyte concentration, as shown in Figure 7. This would carry on
until the chemo-attractant concentration at the boundary, C,e x c e e d s
one or other of the thresholds CTm,CTT,b e y o n dw h i c hp o i n ta n
equilibrium solution is no longer possible. At these points, there would
be increased trans-intimal flux of monocytes and T-lymphocytes from
the lumen, which would result (via (48)) in a continuous increase in
necrotic lesion size, and therefore risk of atherosclerosis. The doses used
here are moderate (10 mGy/day), such as might occur in occupational
exposure settings, and would account for the observed radiation-
associated excess risk that has been seen in various groups of nuclear
workers [10–14]. The model implies that at least until the chemo-
attractant threshold min½CTm,CTT  is exceeded the system is stable,
assuming that the conjecture we make after (56) is valid.
If the chemo-attractant threshold min½CTm,CTT  is exceeded as
a result of the perturbation term, CD, resulting in monocyte or T-
lymphocyte flux across the EC layer, then extra terms need adding
to the right hand side of (44) and (47),
{DmmLbm,1
ð
LVL
CD1bm,0zbm,1½CeqzCD w01CeqzCDwCTmdx ð57Þ
and
{DTTLbT,1
ð
LVL
CD1bT,0zbT,1½CeqzCD w01CeqzCDwCTTdx ð58Þ
respectively. Apparently paradoxically, if Ceqvmin½CTm,CTT ,
then we must have CDw0 for the terms inside the integrals to
contribute non-trivially, and so these terms will be negative and
therefore tend to reduce the averaged levels of monocytes and T-
lymphocytes in the system. By (42) this will tend to increase the
chemo-attractant concentration still further. In other words, once
this chemo-attractant threshold is crossed the system tends (on
average) to become yet more unstable.
There are of course other agents that damage monocytes or ECs
that would cause the chemo-attractant level to increase, so that
although for an individual this threshold might never be passed, in
a large population there would be a continuous (and approxi-
mately linear) increase in cardiovascular risk with dose as shown in
Figure 8. The same phenomenon would also occur at higher doses
(e.g., at radiotherapeutic levels of dose), at a correspondingly
higher level, although the relative magnitude of the perturbations
would make the neglect of all but first order perturbations that we
assumed in deriving (31)–(39) possibly invalid; there is abundant
evidence of radiation-induced disease in groups exposed to certain
forms of RT [6,7]. Critical to our model, and indeed the
understanding of atherosclerosis, is whether there really are such
thresholds in chemo-attractant levels for the trans-intimal
monocyte and T-lymphocyte flux. We assume the presence of
such thresholds for the purposes of our stability analysis, as we
have to if there is to be a stable solution, but it is possible
nevertheless that these thresholds are zero, in which case,
assuming the model is correct, the atherosclerotic process must
be inherently unstable. As indicated above, if this is model is
correct and is to be consistent with the observed cumulative
cardiovascular disease mortality in developed populations [28],
then the chemo-attractant (MCP-1) threshold must lie in the range
[mean+0.256population SD, mean+1.006 population SD] (the
mean and population SD being as in Cannon et al. [27]), in other
words [1.0, 1.7]610
214 Mm l
21.
We implicitly assume that atherosclerosis is mainly responsible
for the observed excess risk of cardiovascular morbidity or
mortality following fractionated low-dose irradiation of the heart
and major arteries. This assumption is supported by experimental
data in ApoE
2/2 mice [35]. However, some human symptoms are
due to (myocardial) ischaemia which could be caused by either
macrovascular (atherosclerotic) or microvascular damage. At
higher (radiotherapy) doses, both human and animal data suggest
that both types of lesion occur [6]. Although the generally high
prevalence of atherosclerosis in humans suggests that this is the
more probable cause of ischaemia following low-dose radiation, it
is possible that microvascular disease also plays a role. It should be
noted that we have been addressing mechanisms for induction of
atherosclerosis following fractionated low-dose radiation to the
large arteries (coronary, carotid etc). There is a large literature on
fibrotic, pericardial, myocardial and other morbidity sequelae of
high-dose irradiation of the heart and large arteries, both for
humans and animals [6]. The pro-inflammatory mechanisms for
these are reasonably well understood, and quite different from
those hypothesized here [36]. That the true mechanisms for low-
dose effects are likely to be very different is also suggested by the
pronounced fractionation effect seen for high-dose exposure in
relation to heart failure in rats [37,38], in contrast to the somewhat
lower risks observed in the Japanese atomic bomb survivors
compared with occupationally exposed groups (Table 1).
Indirect mechanisms for the action of radiation could also be
postulated. At high doses it is clear that inflammatory markers are
up-regulated in vitro and in vivo, although at lower doses if anything
the evidence points to down-regulation of inflammation [16]. In
terms of the model this could be mediated by an increase in radical
flux, which could, via lipid peroxidation, lead to EC damage. This
in turn would lead to an increase in the chemo-attractant signal.
Radiation is known to cause long-term variation in certain T-cell
subpopulations (CD4+) in the Japanese atomic bomb survivors
[39], and this mechanism could also be readily incorporated in the
model. Long-term radiation-associated changes in cholesterol
concentration have been observed in the Japanese atomic bomb
survivors [40], presumably a result of some change in liver
metabolism; these too could be easily incorporated in the model. It
is of interest in this respect that there is a highly statistically
significant trend with internal (plutonium a-particle) dose to the
liver for ischaemic heart disease and cerebrovascular disease in the
latest analysis of the Mayak worker data [14]. Set against that,
there is little evidence of excess risk of circulatory disease risk,
specifically cardiac disease in groups exposed to the diagnostic
contrast medium Thorotrast, which delivered a substantial a-
particle liver dose [41,42].
An important consideration in estimating dose to the intima,
and which may have a bearing on interpretation of certain
epidemiological studies, is the role of oxygen diffusion. This has
been modelled by Richardson [43–45], who has highlighted the
pronounced variations with oxygen concentration across the
intima, which also varies with age as a result of modifications in
arterial geometry [44]. It is well known that with decreasing
oxygenation the effective dose reduces [45], and this implies that
biologically effective dose per unit exposure reduces by 8–12%
from age 0.5 to 70 years, whether for high linear energy transfer
(LET) (
222Rn,
218Po,
214Po) or for low LET radiation [45]. This
needs to be addressed in the dosimetry of any study; assuming that,
as we argue above, intimal dose is of the most relevance to
Model for Cardiovascular Disease
PLoS Computational Biology | www.ploscompbiol.org 9 October 2009 | Volume 5 | Issue 10 | e1000539cardiovascular risk, not doing so would imply a modest negative
bias in modifications of the radiation response by age at exposure.
Whilst the inflammatory process is recognized as an integral
part of the atherosclerotic process [5] it does not explain the
observation that the proliferation of vascular smooth muscle cells
(VSMC) during atherosclerotic plaque development appears to be
monoclonal [46]. Clonality suggests that plaque VSMCs must
have undergone multiple rounds of division, and telomere loss
studies argue that this is between 7–13 cumulative population
doublings [47]. However, clonality itself is not synonymous with
transformation of a single cell, and subsequent studies have shown
that large patches in the normal vessel media are monoclonal
[48,49]. Thus, clonality is more likely to be explained by the
presence of developmental clones in the normal vessel wall, rather
than a mutation. Finally, in contrast to tumours, plaque VSMCs
show poor proliferation, enhanced apoptosis, and early senescence
[50]. These features would not confer a proliferative or survival
advantage to plaque VSMCs. Furthermore, plaque VSMC
proliferation is now seen to be beneficial in atherosclerosis [51],
so that the pathological consequences of a mutation promoting
VSMC proliferation are unclear.
T h el i m i t a t i o n so ft h em o d e l l i n gp e r f o r m e dh e r es h o u l db e
acknowledged.Eveninthefullermodelconsidered inTextS1section
A there is much biology not included – simplifications have been
made for analytical simplicity. Although not strictly a defect in the
model, we assume in our motivating example that a certain (dose-
dependent) fraction of the monocytes are killed instantaneously by
radiation exposure. The magnitude of this fraction is based on data
from a human bone-marrow colony-forming assay (for cells under
hypoxic conditions) of Gordon [30] (Table S3), performed 9 days
after irradiation. It is known that cells take a variable length of time to
die after irradiation, as a result of the repair and mis-repair processes
they are thought to be subject to [52]. As such, a possibly more
realistic scenario would have assumed this total cell damage
exponentially distributed over time rather than occurring instanta-
neously.However,itisunlikelythatthevariabledelayinexpressionof
monocyte mortality, which is likely to be 99.7% complete within
three hours of irradiation [52], will make much difference to the
predictions of our model, concerned as it largely is with the
consequences of fractionated radiation doses separated by days or
more. It would not be too difficult to modify the equations (5), (6) and
(8) to incorporate the simple repair-misrepair model outlined in
Brenner et al. [52], although for the purposes of the present paper we
regard this as an unnecessary elaboration.
That said, the simpler model proposed here we trust captures
what is known about the main features of interaction of oxidized
LDL and various other molecular species (MCP-1, G-CSF, bound
lipid) with the various cellular species (monocytes, macrophages,
T-lymphocytes) that are known to be of significance for induction
of atherosclerosis. The mathematics underlying these reaction and
diffusion processes is reasonably standard. What is interesting and
novel about the present paper is that using only experimentally
derived parameters (taken wherever possible from human data)
(Tables S2, S3) we have reproduced what is observed in other
experimental and epidemiologic data (Figures 7–8, Table 1).
This proposed mechanism would in principle be experimentally
testable. This would best be done in vitro, looking for changes in
MCP-1 levels, or other potential chemo-attractants, in a co-culture
system similar to that developed by Takaku et al. [25]. This could
be explored under a range of radiation exposure conditions (both
localized and fractionated) and subsequent effects on, for example,
adhesion properties could also be examined. In vivo experiments
would be more complex (and expensive), but could also be
performed, for example, using the ApoE
2/2 knockout mouse
model employed by Stewart et al. [35,53]. Even human data could
be envisaged. In particular, if arterial tissue could be sampled from
patients who have, a short time previously, received low-dose
radiotherapy or high-dose diagnostic procedures (e.g., computer-
ized tomography), together with suitable (age-matched) controls,
one could determine whether intimal concentration of MCP-1 was
significantly increased and the manner in which concentration
changed with dose.
If the proposed mechanism were true, it also has substantive
implications for radiological protection, which at present does not
take cardiovascular disease into account [54]. Analysis of the
Japanese atomic bomb survivor data implies that non-cancer
disease mortality, in particular cardiovascular mortality, contrib-
utes almost equally as cancer mortality to the radiogenic excess
risk [8]. The major uncertainty in assessing the low-dose risk of
cardiovascular disease is the shape of the dose response
relationship, which is very unclear in the Japanese data [8,55].
The analysis of the present paper suggests that linear extrapolation
would be generally appropriate for this endpoint.
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